期刊文献+

静脉输注卡铂致过敏的报道及药学服务 被引量:5

Case report of hypersensitivity reactions to carboplatin and pharmacy service
原文传递
导出
摘要 目的:为临床安全使用卡铂提供药学信息和药学服务。方法:报告卡铂化疗中出现的3例不良反应,包括2例胸闷憋气、血压下降和1例严重的过敏性休克。结合案例对卡铂过敏的报道进行文献检索分析。结果:根据病例及文献汇总,分析卡铂过敏反应的发生特点、机制、危险因素、预防方式以及后续治疗方法,总结卡铂过敏反应的相关药学信息和药学服务要点。结论:药师通过临床治疗实践,获得积累卡铂过敏反应的相关知识和经验并为临床治疗选择提供药学服务。 Objective: To provide the pharmaceutical information and pharmacy service for clinically safe use of the cancer therapeutic agent carboplatin. Methods: Three cases of adverse reactions caused by carboplatin were reported. Two patients developed chest distress, breath holding, and hypotension; and one patient developed severe anaphylactic shock. The relevance to carboplatin hypersensitivity was reviewed. Results: From the cases and literature review, we summarized the incidence, clinical features, management, risk factors, predicting method, outcome and following treatments of carboplatin-related hypersensitivity reaction. We also obtained relevant pharmaceutical information. Conclusion: Pharmacists' knowledge of carboplatin-related hypersensitivity reaction and management options is useful to make a better medicinal decision.
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第3期339-342,共4页 Chinese Journal of New Drugs
关键词 卡铂 过敏反应 药学服务 carboplatin hypersensitivity reaction pharmacy service
  • 相关文献

参考文献27

  • 1AKIKO A, HIROSHI I, SAKI I. Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer[ J ]. J Med Investigation, 2010, 57 ( 1 - 2 ) : 163 - 168.
  • 2王含必,沈铿,杨佳欣,黄惠芳,李颖,吴鸣,潘凌亚.卡铂超敏反应13例临床分析[J].中华妇产科杂志,2009,44(11):837-840. 被引量:10
  • 3POLYZOS A,TSAVARIS N,KOSMAS C, et al. Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience [ J]. Oncology, 2001, 61 (2) : 129 - 133.
  • 4MARISA N, ANURADHA K, MARTINA L, et al. Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients [ J ]. Gynecologic Oncology, 2006, 103 (2) : 608 - 613.
  • 5KOSHIBA H, HOSOKAWA K, KUDO A, et al. Incidence of carboplatin-ralated hypersensitivity reactions in Japanese patients with gynecologic malignancies[ J].Int J Gynecol Cancer, 2009, 19(3) : 460 -465.
  • 6GADDUCCI A, TANA R, TETI G, et al. Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin re- treatment for recurrent ovarian cancer[J]. Int J Gynecol Cancer, 2008,18(4) :615 -620.
  • 7LAURA W, MAURIE M. Hypersensitivity following retreatment with carboplatin a decade after completion of primary platinum- based chemotherapy[J]. Case Rep Oncol, 2009, 2(1): 20-23.
  • 8MARKMAN M, ZANOTTI K, KULP B, et al. Relationship be- tween a history of systemic allergic reactions and risk of subse- quent carboplatin hypersensitivity [ J ]. Gynecol Oncol, 2003, 89 (3) :514 -516.
  • 9SCHWARTZ JR, BANDERA C, BRADLEY A, et al. Does the platinum-free interval predict the incidence or severity of hyper- sensitivity reactions to carboplatin? The experience from Women and Infants' Hospital[ J]. Gynecol Oncol, 2007,105( 1 ) :81 -83.
  • 10MARKMAN M, ZANOTTI K, PETERSON G, et al. Expanded experience with an intradermal skin test to predict for the pres- ence or absence of carboplatin hypersensitivity[J]. J Clin Oncol, 2003, 21(24) : 4611 -4614.

二级参考文献8

  • 1Callahan MB, Lachance JA, Stone RL, et al. Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer. Am J Obstet Gynecol, 2007, 197 : 199-200.
  • 2Lenz HJ. Management and preparedness for infusion and hypersensitivity reactions. Oncologist, 2007, 12: 601-609.
  • 3Navo M, Kunthur A, Badell ML, et al. Evaluation of the incidence of carboplatin reactions in cancer patients. Gynecol Oncol, 2006, 103 : 608-613.
  • 4Sliesoraitis S, Chikhale PJ. Carboplatin hypersensitivity. Int J Gynecol Cancer, 2005, 15 : 13-18.
  • 5The National Comprehensive Cancer Network, Inc. 2009 NCCN clinical practice guidelines in oncology: ovarian cancer [ EB/ OL ]. [ 2009-9-24 ] . http://www, nccn. org/professionals/ physician_gls/f_guidelines, asp.
  • 6Koshiba H, Hosokawa K, Kubo A, et al. Incidence of carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies. Int J Gynecol Cancer, 2009, 19: 460-465.
  • 7Hesterberg PE, Banerji A, Oren E, et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity : clinical presentation and management. J Allergy Clin Immunol, 2009, 123: 1262-1267.
  • 8Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Alllergy Clin Immunol, 2008, 122, 574-580.

共引文献9

同被引文献14

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部